Semiquantitative assay of human chorionic gonadotropin by a simple and fast immunofiltration technique

A Rapak1, A Szewczuk

  • 1Laboratorium Biochemii, Instytut Immunologii i Terapii Doświadczalnej PAN, Wrocław, Polska.

European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies
|March 1, 1993
PubMed

Insights

This study introduces a new immunofiltration assay for human chorionic gonadotropin (hCG). The assay accurately detects hCG in urine and serum, showing promise for diagnosing pregnancy and trophoblastic diseases.

Area of Science:

  • Biochemistry
  • Immunology
  • Medical Diagnostics

Background:

  • Human chorionic gonadotropin (hCG) is a crucial biomarker for pregnancy and certain cancers.
  • Accurate and accessible detection methods for hCG are vital in clinical settings.

Purpose of the Study:

  • To develop and validate a novel immunofiltration technique for the semiquantitative assay of human chorionic gonadotropin (hCG).
  • To compare the specificity and utility of two antibody-based approaches within the immunofiltration assay.

Main Methods:

  • An immunofiltration assay was developed using immobilized anti-beta hCG subunit antibodies on a microfibre disc.
  • Two versions were tested: one using monoclonal antibodies specific for intact hCG, and another using rabbit antibodies detecting both intact hCG and its beta-chain.
  • Colorimetric detection was achieved using a horse radish peroxidase conjugate and tetramethylbenzidine/hydrogen peroxide solution.

Main Results:

  • The assay demonstrated a concentration-dependent colorimetric response, with blue bar formation indicating hCG presence.
  • The monoclonal antibody version was specific for intact hCG, while the rabbit antibody version detected both intact hCG and its beta-chain.
  • Negligible cross-reactivity with human lutropin and thyrotropin was observed, and common substances like hemoglobin, urea, and drugs did not interfere.
  • Results correlated well with established ELISA and commercial kit methods when tested on urine from pregnant women and sera from patients with trophoblastic diseases.

Conclusions:

  • The developed immunofiltration technique offers a reliable and specific method for semiquantitative hCG detection.
  • This assay is suitable for clinical applications, including pregnancy testing and monitoring trophoblastic diseases.
  • The assay's performance is comparable to existing gold-standard methods, suggesting its potential for widespread adoption.

Related Concept Videos